肽核酸，類肽和多肽定制合成服務(wù)以及肽核酸單體，類肽單體
普通會(huì)員
產(chǎn)品價(jià)格面議
產(chǎn)品品牌賽曼諾生物
最小起訂≥5 mg
供貨總量1000 mg
發(fā)貨期限自買家付款之日起 3 天內(nèi)發(fā)貨
瀏覽次數(shù)61
企業(yè)旺鋪http://cellmano.sjooo.com/
更新日期2015-02-06 13:44
會(huì)員級(jí)別：企業(yè)會(huì)員
已 繳 納：0.00 元保證金
我的勛章： [誠(chéng)信檔案]
在線客服：
企業(yè)二維碼： 企業(yè)名稱加二維碼
品牌： |
賽曼諾生物 |
所在地： |
安徽 合肥市 |
起訂： |
≥5 mg |
供貨總量： |
1000 mg |
有效期至： |
長(zhǎng)期有效 |
| (Leu31,Pro34)-Neuropeptide Y (13-36) (human, rat) | C134H206N39O35S | 2969.42 | 302798-54-5 | H-Pro-Ala-Glu-Asp-Met-Ala-Arg-Tyr-Tyr-Ser-Ala-Leu-Arg-His-Tyr-Ile-Asn-Leu-Leu-Thr-Arg-Pro-Arg-Tyr-NH2 |
| Neuropeptide Y (13-36) (porcine) | C135H209N41O36 | 2982.40 | 113662-54-7 | H-Pro-Ala-Glu-Asp-Leu-Ala-Arg-Tyr-Tyr-Ser-Ala-Leu-Arg-His-Tyr-Ile-Asn-Leu-Ile-Thr-Arg-Gln-Arg-Tyr-NH2 |
| Neuropeptide Y (18-36) | C112H174N36O27 | 2456.84 | 114495-97-5 | H-Ala-Arg-Tyr-Tyr-Ser-Ala-Leu-Arg-His-Tyr-Ile-Asn-Leu-Ile-Thr-Arg-Gln-Arg-Tyr-NH2 |
| Pancreatic Polypeptide (1-17)-(Ala31,Aib32)-Neuropeptide Y (18-36) (human) | C189H287N55O53S | 4209.76 | 313988-70-4 | H-Ala-Pro-Leu-Glu-Pro-Val-Tyr-Pro-Gly-Asp-Asn-Ala-Thr-Pro-Glu-Gln-Met-Ala-Arg-Tyr-Tyr-Ser-Ala-Leu-Arg-His-Tyr-Ile-Asn-Leu-Ala-Aib-Arg-Gln-Arg-Tyr-NH2 |
| Neuropeptide Y (22-36) | C85H139N29O21 | 1903.22 | 119019-65-7 | H-Ser-Ala-Leu-Arg-His-Tyr-Ile-Asn-Leu-Ile-Thr-Arg-Gln-Arg-Tyr-NH2 |
| Acetyl-(Leu28·31)-Neuropeptide Y (24-36) Acetyl-(Leu28·31)-NPY (24-36) |
C81H131N27O19 | 1787.10 | 155709-24-3 | Ac-Leu-Arg-His-Tyr-Leu-Asn-Leu-Leu-Thr-Arg-Gln-Arg-Tyr-NH2 |
| Tyr-Lys-Gly-(Cyclo(Glu26-Lys29),Pro34)-Neuropeptide Y (25-36) | C91H145N27O20 | 1937.32 | 185032-24-0 | H-Tyr-Lys-Gly-Arg-cyclo(-Glu-Tyr-Ile-Lys)-Leu-Ile-Thr-Arg-Pro-Arg-Tyr-NH2 |
| (D-Tyr27·36,D-Thr32)-Neuropeptide Y (27-36) | C61H99N19O15 | 1338.58 | 163887-48-7 | H-D-Tyr-Ile-Asn-Leu-Ile-D-Thr-Arg-Gln-Arg-D-Tyr-NH2 |
| ((Cys31,Nva34)-Neuropeptide Y (27-36))2 | C116H186N36O28S2 | 2597.11 | 172997-92-1 | (H-Tyr-Ile-Asn-Leu-Cys-Thr-Arg-Nva-Arg-Tyr-NH2)2 (Disulfide bond) |
| (Pro30,Tyr32,Leu34)-Neuropeptide Y (28-36) GR231118 |
C57H91N17O12 | 1206.46 | 161650-01-7 | H-Ile-Asn-Pro-Ile-Tyr-Arg-Leu-Arg-Tyr-NH2 |
| (His32,Leu34)-Neuropeptide Y (32-36) | C33H54N14O6 | 742.88 | 168916-68-5 | H-His-Arg-Leu-Arg-Tyr-NH2 |
| DL-2,7-Diaminosuberoyl-((Tyr32,Leu34)-Neuropeptide Y (32-36))2 | C80H124N26O16 | 1706.03 | 887332-81-2 | DL-2,7-Diaminosuberoyl-(Tyr-Arg-Leu-Arg-Tyr-NH2)2 Trifluoroacetate salt |
| (Gly1,Ser3·22,Gln4·34,Thr6,Arg19,Tyr21,Ala23·31,Aib32)-Pancreatic Polypeptide (human) (Gly1,Gln4·16,Thr6·13,Tyr7,Asp10,Asn11,Pro14,Arg26,Met30,Ala31,Aib32)-Neuropeptide Y (human, rat) |
C183H281N57O54S2 | 4207.73 | 313988-89-5 | H-Gly-Pro-Ser-Gln-Pro-Thr-Tyr-Pro-Gly-Asp-Asn-Ala-Thr-Pro-Glu-Gln-Met-Ala-Arg-Tyr-Tyr-Ser-Ala-Leu-Arg-Arg-Tyr-Ile-Asn-Met-Ala-Aib-Arg-Gln-Arg-Tyr-NH2 Trifluoroacetate salt |
| PYX-1 | C70H105Cl2N19O16 | 1539.63 | 140842-17-7 | Ac-3-(2,6-dichloro-Bzl)-Tyr-Ile-Asn-Leu-Ile-D-Thr-Arg-Gln-Arg-Tyr-NH2 Trifluoroacetate salt |
| Neurotensin | C78H121N21O20 | 1672.95 | 55508-42-4 | Pyr-Leu-Tyr-Glu-Asn-Lys-Pro-Arg-Arg-Pro-Tyr-Ile-Leu-OH |
| (Gln4)-Neurotensin | C78H122N22O19 | 1671.96 | 61445-54-3 | Pyr-Leu-Tyr-Gln-Asn-Lys-Pro-Arg-Arg-Pro-Tyr-Ile-Leu-OH |
| (Trp11)-Neurotensin | C80H122N22O19 | 1695.99 | 75644-95-0 | Pyr-Leu-Tyr-Glu-Asn-Lys-Pro-Arg-Arg-Pro-Trp-Ile-Leu-OH |
| (D-Trp11)-Neurotensin | C80H122N22O19 | 1695.99 | 100929-52-0 | Pyr-Leu-Tyr-Glu-Asn-Lys-Pro-Arg-Arg-Pro-D-Trp-Ile-Leu-OH |
| (D-Tyr11)-Neurotensin | C78H121N21O20 | 1672.95 | 64088-62-6 | Pyr-Leu-Tyr-Glu-Asn-Lys-Pro-Arg-Arg-Pro-D-Tyr-Ile-Leu-OH |
| Neurotensin (1-6) | C35H52N8O12 | 776.85 | 87620-09-5 | Pyr-Leu-Tyr-Glu-Asn-Lys-OH |
| Neurotensin (1-8) | C46H71N13O14 | 1030.15 | 80887-44-1 | Pyr-Leu-Tyr-Glu-Asn-Lys-Pro-Arg-OH |
| Neurotensin (1-11) | C66H99N19O18 | 1446.63 | 74032-89-6 | Pyr-Leu-Tyr-Glu-Asn-Lys-Pro-Arg-Arg-Pro-Tyr-OH |
| Neurotensin (8-13) | C38H64N12O8 | 817.00 | 60482-95-3 | H-Arg-Arg-Pro-Tyr-Ile-Leu-OH |
| Acetyl-Neurotensin (8-13) | C40H66N12O9 | 859.04 | 74853-69-3 | Ac-Arg-Arg-Pro-Tyr-Ile-Leu-OH |
| (Dab9)-Neurotensin (8-13) | C36H60N10O8 | 760.94 | 166824-25-5 | H-Arg-Dab-Pro-Tyr-Ile-Leu-OH |
| (Lys8,Lys9)-Neurotensin (8-13) | C38H64N8O8 | 760.98 | 139026-64-5 | H-Lys-Lys-Pro-Tyr-Ile-Leu-OH |
| (Lys9,Trp11,Glu12)-Neurotensin (8-13) (Cyclic Analog) | C39H59N11O8 | 809.97 | 160662-16-8 | Cyclo(-Arg-Lys-Pro-Trp-Glu)-Leu-OH |
| Neurotensin (9-13) | C32H52N8O7 | 660.81 | 60482-96-4 | H-Arg-Pro-Tyr-Ile-Leu-OH |
| Brain Injury Derived Neurotrophic Peptide BINP |
C62H102N18O18 | 1387.60 | 148330-12-5 | H-Glu-Ala-Leu-Glu-Leu-Ala-Arg-Gly-Ala-Ile-Phe-Gln-Ala-NH2 |
| Neurotrophic Factor for Retinal Cholinergic Neurons | C53H84N12O16 | 1145.32 | 156707-52-7 | H-Tyr-Leu-Leu-Pro-Ala-Gln-Val-Asn-Ile-Asp-OH Trifluoroacetate salt |
本網(wǎng)頁(yè)所展示的有關(guān)【PYX-1,Neurotensin_生化試劑_合肥賽曼諾生物科技有限公司】的信息/圖片/參數(shù)等由商一網(wǎng)的會(huì)員【合肥賽曼諾生物科技有限公司】提供，由商一網(wǎng)會(huì)員【合肥賽曼諾生物科技有限公司】自行對(duì)信息/圖片/參數(shù)等的真實(shí)性、準(zhǔn)確性和合法性負(fù)責(zé)，本平臺(tái)（本網(wǎng)站）僅提供展示服務(wù)，請(qǐng)謹(jǐn)慎交易，因交易而產(chǎn)生的法律關(guān)系及法律糾紛由您自行協(xié)商解決，本平臺(tái)（本網(wǎng)站）對(duì)此不承擔(dān)任何責(zé)任。您在本網(wǎng)頁(yè)可以瀏覽【PYX-1,Neurotensin_生化試劑_合肥賽曼諾生物科技有限公司】有關(guān)的信息/圖片/價(jià)格等及提供【PYX-1,Neurotensin_生化試劑_合肥賽曼諾生物科技有限公司】的商家公司簡(jiǎn)介、聯(lián)系方式等信息。
在您的合法權(quán)益受到侵害時(shí)，歡迎您向郵箱發(fā)送郵件，或者進(jìn)入《網(wǎng)站意見反饋》了解投訴處理流程，我們將竭誠(chéng)為您服務(wù)，感謝您對(duì)商一網(wǎng)的關(guān)注與支持！
